Abstract
IntroductionGlobal actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consumers. In Bangladesh, there is limited research on household decision-making and healthcare seeking in relation to antibiotic use and consumption for humans and livestock. Knowledge is similarly lacking on factors influencing the supply and demand for antibiotics among qualified and unqualified healthcare providers.The aim of this study is to conduct integrated research on household decision-making for healthcare and antibiotic use, as well as the awareness, behaviours and priorities of healthcare providers and sellers of antibiotics to translate into policy development and implementation.Methods and analysisIn-depth interviews will be conducted with (1) household members responsible for decision-making about illness and antibiotic use for family and livestock; (2) qualified and unqualified private and government healthcare providers in human and animal medicine and (3) stakeholders and policy-makers as key informants on the development and implementation of policy around AMR. Participant observation within retail drug shops will also be carried out. Qualitative methods will include a thematic framework analysis.A holistic approach to understanding who makes decisions on the sale and use of antibiotics, and what drives healthcare seeking in Bangladesh will enable identification of routes to behavioural change and the development of effective interventions to reduce the health risks of AMR.Ethics and disseminationApproval for the study has been obtained from the Institutional Review Board at the International Centre for Diarrhoeal Disease Research, Bangladesh following review by the Research and Ethics Committees (PR-16100) and from Loughborough University (R17-P081). Information about the study will be provided in a participant information letter in Bangla (to be read verbally and given in writing to participants). A written informed consent form in Bangla will be obtained and participants will be informed of their right to withdraw from the study. Dissemination will take place through a 1 day dissemination workshop with key stakeholders in public health and policy, practitioners and scientists in Bangladesh, and through international conference presentations and peer-review publications. Anonymised transcripts of interviews will be made available through open access via institutional data repositories after an embargo period.
Funder
Economic and Social Research Council
Economic and Social Research CouncilEconomic and Social Research Council
Reference30 articles.
1. WHO. Worldwide country situation analysis: response to antimicrobial resistance. 2015 http://www.who.int/drugresistance/documents/situationanalysis/en/ (Accessed 25 Nov 2018).
2. Biswas M , Roy MN , Manik MI , et al . Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi City. BMC Public Health 2014;14:847.doi:10.1186/1471-2458-14-847
3. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?;Mohiuddin;BMC Med Ethics,2015
4. SIAPS. Baseline study of private drug shops in Bangladesh: findings and recommendations. 2015 http://siapsprogram.org/publication/altview/baseline-study-of-private-drug-shops-in-bangladesh-findings-and-recommendations/english/ (Accessed 25 Nov 2018).
5. Availability and rational use of drugs in primary healthcare facilities following the national drug policy of 1982: is Bangladesh on right track?;Ahmed;J Health Popul Nutr,2012
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献